Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
8.37
-0.06 (-0.71%)
At close: Jul 19, 2024, 4:00 PM
8.70
+0.33 (3.94%)
Pre-market: Jul 22, 2024, 8:28 AM EDT
Voyager Therapeutics Employees
Voyager Therapeutics had 162 employees as of December 31, 2023. The number of employees increased by 37 or 29.60% compared to the previous year.
Employees
162
Change (1Y)
37
Growth (1Y)
29.60%
Revenue / Employee
$734,840
Profits / Employee
-$18,790
Market Cap
455.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bioventus | 970 |
Pacific Biosciences of California | 796 |
Nano-X Imaging | 164 |
Absci | 155 |
Nkarta | 150 |
MaxCyte | 143 |
EyePoint Pharmaceuticals | 121 |
Theravance Biopharma | 99 |
VYGR News
- 12 days ago - Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Voyager Therapeutics to Present at Multiple Virtual Investor Conferences - GlobeNewsWire
- 5 weeks ago - Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast - GlobeNewsWire
- 3 months ago - Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting - GlobeNewsWire